Addressing recent concerns about vaccines, Dr Hans Kluge also said the risk of people suffering blood clots is far higher for people with Covid-19 than people who receive AstraZeneca's coronavirus vaccine.
Speaking to reporters during a visit to Greece, Kluge did point to “early signs that transmission may be slowing across several countries” and cited “declining incidence” among the oldest people.
Also Read
“For now, the risk of suffering blood clots is much higher for someone with Covid-19 than for someone who has taken the AstraZeneca vaccine,” he said.
“Let there be no doubt about it, the AstraZeneca vaccine is effective in reducing Covid-19 hospitalisation and preventing deaths,” he added, saying WHO recommends its use for all eligible adults.
Denmark looking to share its unwanted Astra vaccines
Denmark is examining options for sharing AstraZeneca’s vaccines with poorer nations after it halted use of the shots over concerns about rare blood clots, the World Health Organizations Europe head said.
The WHO has been pushing countries not to hoard vaccines that they are not using. Reuters
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)